Cadence Expands TSMC Partnership With A14 Certification and UALink IP

Business Wire··TWUS·Read original
3▲3 ▼0Impact / 5
Summary · why it matters

Cadence announced an expanded partnership with TSMC to deliver certified tool flows and silicon-proven IP for AI and HPC designers on TSMC's most advanced processes. Cadence has achieved tool certification for TSMC's A14 process, demonstrated an industry-leading UALink solution in TSMC N3P, and introduced new silicon-proven IP for N3P and N2P technologies. The collaboration enables agentic AI chip and 3D-IC design flows across TSMC's N3, N2, A16 and A14 process technologies, including TSMC 3DFabric support for wafer-scale systems with hundreds of chiplets. Cadence's digital full flow, signoff flow, and custom/analog flows are now certified for TSMC A16 and A14, with Virtuoso Studio solutions reducing iterations by up to 2.5X, while UCIe-64G has been taped out on A14 and Artisan Foundation IP for A14 is expected to be available in Q4 2026. Cadence analog, digital, and signoff tool flows have also been certified for TSMC N2P, with taped-out N2P IP including DDR5, LPDDR5, and PCIe 6.0, and PCIe 3.0 IP expected to tape out in Q4 2026. Global Unichip Corp. is leveraging Cadence solutions to deliver advanced custom silicon for AI accelerators and hyperscale systems on TSMC's leading-edge process technologies.

Impact on assets 3

Semiconductors▲
Global Unichip Corp
3443
▲ PositiveDemandrelevance

Global Unichip is leveraging Cadence solutions to deliver advanced custom silicon for AI accelerators and hyperscale systems on TSMC leading-edge processes.

Artificial Intelligence▲
Cadence Design Systems Inc
CDNS
▲ PositiveTechnologyrelevance

Cadence achieved TSMC A14 tool certification and introduced silicon-proven UALink, UCIe-64G, and N3P/N2P IP, expanding its design-flow and IP offerings.

Theme Impact 6

Related news

United States
▲

HSBC Upgrades Synopsys to Buy, Lifts Price Target to $700

HSBC upgraded Synopsys to Buy from Hold on September 25 and raised its price target from $490 to $700, implying a multiple of nearly 35 times HSBC's fiscal 2027 EPS estimates. Analyst Frank Lee said the company is evolving beyond its traditional slow-growth software profile as its licensing-plus-royalty model and agentic AI tools create a new path to benefit from AI. The upgrade follows Synopsys' fiscal third-quarter results, when revenue rose 42% to $2.48 billion, including approximately $711 million from Ansys, alongside higher full-year guidance. Synopsys announced a multiyear agreement worth more than $1 billion with Amazon on September 30, combining IP licensing with production-linked royalties, though the company has said revenue synergies from Ansys will not begin until fiscal 2027. The stock trades at approximately 61 times the midpoint of management's fiscal 2027 GAAP EPS guidance, or roughly 28 times adjusted earnings, and carries about $7 billion more debt than cash, largely tied to the Ansys deal.
About megatrends
Semiconductors › EDA & Semiconductor IP ▲Technology
Artificial Intelligence › EDA & Semiconductor IP ▲Technology
SNPS · Capital · Positive HSBC upgraded Synopsys to Buy and raised its price target from $490 to $700.
SNPS · Demand · Positive Synopsys signed a multiyear agreement worth over $1 billion with Amazon for IP licensing and royalties.
AMZN · Demand · Positive Synopsys announced a multiyear agreement worth more than $1 billion with Amazon combining IP licensing and production-linked royalties.
Read original ↗
Insider Monkey·21hRead more →
United States
▲2impact 4

Synopsys Touts Amazon and OpenAI AI Deals, Raises Fiscal 2027 Outlook

Synopsys unveiled a major agreement with Amazon covering its intellectual property across custom silicon programs including Trainium, Graviton and Nitro, alongside a partnership with OpenAI to develop GPT-Synopsys, a specialized AI model for semiconductor design. The Amazon deal introduces a royalty-based component tied to chip production. Management also issued a stronger-than-expected outlook, projecting fiscal 2027 revenue of $11.10–$11.20 billion, above the roughly $10.81 billion analysts had expected, and non-GAAP earnings guidance of $19.04–$19.12 per share versus prior consensus near $17.81. The company now targets roughly 15% annual revenue growth through fiscal 2030, with operating margins approaching 50% and annual adjusted EPS growth in the mid-20% range, and intends to repurchase approximately $1 billion in shares over the coming months with a longer-term goal of returning up to 50% of free cash flow to shareholders. Synopsys currently holds a Zacks Rank #1 (Strong Buy), and over the last 60 days the consensus earnings estimate has risen 6.1% to $18.26 per share, with five upward revisions and one downward revision.
About megatrends
Semiconductors › EDA & Semiconductor IP ▲Technology
Artificial Intelligence › EDA & Semiconductor IP ▲Technology
Artificial Intelligence › AI Compute & Accelerator Silicon ▲Technology
Artificial Intelligence › Custom Silicon / ASIC ▲Technology
SNPS · Capital · Positive Synopsys raised fiscal 2027 revenue/EPS outlook above consensus and plans ~$1B buyback with up to 50% FCF returns.
SNPS · Demand · Positive Synopsys unveiled major Amazon IP agreement and OpenAI partnership to develop GPT-Synopsys for chip design.
AMZN · Demand · Positive Amazon agreement covers Synopsys IP across its custom silicon programs (Trainium, Graviton, Nitro), a concrete product deal.
OpenAI · Technology · Positive OpenAI partnership with Synopsys to develop GPT-Synopsys, a specialized AI model for semiconductor design.
Read original ↗
Zacks Investment Research·2dRead more →
United States
▲

Cadence Design Systems Eyes Another Earnings Beat on Positive ESP

Cadence Design Systems is positioned to potentially beat earnings estimates again when it reports on October 26, 2026, according to Zacks Investment Research. The chip-design software maker has topped consensus estimates in each of its last two quarters, with an average surprise of 3.59%. In the most recent quarter, Cadence reported earnings of $2.11 per share against an expected $2.05, a surprise of 2.93%, following a prior-quarter surprise of 4.26% when it posted $1.96 per share versus a $1.88 consensus. The stock currently carries a Zacks Earnings ESP of +0.56% and a Zacks Rank #2 (Buy), a combination Zacks research shows produces a positive surprise nearly 70% of the time.
About megatrends
Semiconductors › EDA & Semiconductor IP ▲Technology
Artificial Intelligence › EDA & Semiconductor IP ▲Technology
CDNS · Capital · Positive Zacks sees Cadence beating earnings estimates again, citing positive ESP and a #2 Buy rank after two straight beats.
Read original ↗
Zacks Investment Research·2dRead more →
United StatesUnited Kingdom
3impact 4

Arm Holdings and Qualcomm Head to Federal Trial Over Billions in Royalty Payments

Arm Holdings and Qualcomm have entered a high-stakes federal trial over alleged breaches of their chip licensing agreements, centering on billions of dollars in potential royalty payments tied to Qualcomm designs that incorporate Arm architecture. Legal arguments focus on whether Qualcomm's use of Arm technology through certain partners falls within existing contract terms or requires fresh licenses, and Qualcomm is seeking to stop paying some royalties for up to five years. Arm Holdings licenses CPU, graphics and systems IP that underpins many smartphone and data-center chips, so the case puts the focus on how this US$323.2 billion semiconductor business enforces and monetises its core designs when large customers route production through complex partner structures. A ruling that weakens Arm's ability to enforce contracts with a large customer could challenge the thesis that rising royalty rates and AI-focused data center royalties support higher earnings. Investors can track the trial timetable through 2026, watch for interim rulings on contract interpretation, and scan Arm's future filings for quantified commentary on Qualcomm-related royalty exposure or any changes to licensing terms with big chip customers.
About megatrends
Semiconductors › EDA & Semiconductor IP Pricing
Artificial Intelligence › EDA & Semiconductor IP Pricing
Semiconductors › Logic, Compute & Connectivity Processors Pricing
Artificial Intelligence › AI Compute & Accelerator Silicon Pricing
Artificial Intelligence › Edge & On-device AI Silicon Pricing
ARM · Regulation · Negative Federal trial over Arm's chip licensing agreements with Qualcomm could weaken its ability to enforce contracts and collect royalties from a large customer.
QCOM · Regulation · Neutral Qualcomm is seeking to stop paying some Arm royalties for up to five years, but the trial's outcome on contract interpretation is uncertain.
Read original ↗
Simply Wall St·3dRead more →
China
▲2

Empyrean Technology Plans to Acquire 6.90% Stake in X-Epic for 149 Million Yuan

Empyrean Technology announced that it plans to invest 149 million yuan to acquire 9.269142 million shares of X-Epic held by Shengshi Zhida. Upon completion of the transaction, Empyrean Technology will hold a 6.90% equity stake in X-Epic, making it an associated company. The company said the investment aims to fill a key gap in placement and routing EDA tools and accelerate the construction of a full-flow EDA tool system for digital circuit design.
About megatrends
Semiconductors › EDA & Semiconductor IP ▲Capital
Artificial Intelligence › EDA & Semiconductor IP ▲Capital
301269.CS · Capital · Positive Empyrean plans to invest 149 million yuan for a 6.90% stake in X-Epic, making it an associated company.
芯行纪科技股份有限公司 · Capital · Positive X-Epic gains Empyrean as a 6.90% shareholder via the 149 million yuan stake purchase.
盛世智达 · Capital · Neutral Shengshi Zhida is the seller of 9.269142 million X-Epic shares to Empyrean for 149 million yuan.
Read original ↗
United States

Synopsys Signs $1 Billion Accelerated Share Repurchase With JPMorgan

Synopsys has entered into a $1 billion accelerated share repurchase agreement with JPMorgan Chase Bank, National Association. Under the terms of the ASR, the Sunnyvale, California-based chip design software company will receive an initial delivery of approximately 1,735,000 shares, with any remainder to be settled on or before January 5, 2027. The final number of shares Synopsys repurchases will be based on the average of its daily volume-weighted average share prices during the repurchase period, less a discount. Synopsys trades on Nasdaq under the ticker SNPS.
About megatrends
Semiconductors › EDA & Semiconductor IP Capital
Artificial Intelligence › EDA & Semiconductor IP Capital
SNPS · Capital · Positive Synopsys signs a $1 billion accelerated share repurchase agreement, a buyback that returns capital to shareholders.
Read original ↗
PR Newswire·5dRead more →